EFMC-ISMC 2012

22nd International Symposium on Medicinal Chemistry

 Berlin, Germany    September 2-6, 2012

Session topics


  • Antibody-Drug Conjugates - Finally Ready for Prime Time? (ACS Session I)
  • Antiinfectives and the Resistance Problem
  • Challenges and Opportunities for Drug Metabolism in Drug Discovery and Preclinical Drug Development (AFMC Session)
  • Chemical Biology Approaches in Drug Discovery
  • Chemistry and Stem-cell Research - Small Molecule Modulation of Stem Cells for Regenerative Medicines
  • Designing Better Drugs: Ligand Efficiency Guided Optimization in Drug Discovery (ACS Session II)
  • Drug Safety: what Toxic Effects can be Reasonably Predicted?
  • Epigenetics - An Area Offering Formidable Challenges and Opportunities for Medicinal Chemists
  • Fighting Cancer : Kinases and Beyond
  • First Time Disclosures
  • From Nano to Macro (EuCheMS Session)
  • Hot Trends in Process Chemistry
  • Intractable targets: is Bigger Better?
  • Late Breaking News
  • Metabolic Disorders
  • Molecular Therapies for Inflammatory and Autoimmune Diseases
  • New Developments in CNS Drug Research
  • New Opportunities in Lead Discovery
  • New Promising Developments
  • New Small Molecule Approaches for Neglected Diseases
  • Next Generation of Cardiovascular Drugs
  • Predictive Tools, Virtual Screening and Cheminformatics
  • Recent Highlights in Medicinal Chemistry
  • Strategies to Tackle Challenging Targets in Oncology
  • Targeting Protein-protein Interactions
  • The impact of Transporters in Drug Discovery and Oral Bioavailability Enhancement (EUFEPS Session)
  • What's New in GPCR Research?